Jan. 11, 2006 — The US Food and Drug Administration (FDA) and Ortho-Clinical Diagnostics, Inc, have notified healthcare professionals regarding a class 1 recall of the VITROS Immunodiagnostic HBsAg ...
Nov. 11, 2002 — Hepatitis B surface antigen (HBsAg)-positive renal transplant patients have improved survival if they are preemptively treated with lamivudine, according to the results of a ...
Phase Ib study combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL). This is an ASCO ...
According to study findings published in PLoS One, researchers found that cancer patients positive for hepatitis B surface antigen who underwent chemotherapy without adequate antiviral prophylaxis ...
Please provide your email address to receive an email when new articles are posted on . The highest percentages of patients with HBsAg loss were observed in the groups that received xalnesiran plus an ...
Role of radiotherapy in patients with early-stage diffuse large B cell lymphoma who had achieved complete remission after chemotherapy. This is an ASCO Meeting Abstract from the 2015 ASCO Annual ...
Background PD-1 blockade has emerged as a promising approach for functional cure of chronic hepatitis B (CHB). Objective This study aimed to evaluate the safety profile of anti-PD-1 antibody (αPD-1), ...
To investigate the frequencies of dendritic cells (DCs) and Toll-like receptor 3 (TLR3) in neonates of HBsAg-positive mothers with different HBV serological profiles, we conducted a study in Taiyuan, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback